Farhat F.S.; Tfayli A.; Fakhruddin N.; Mahfouz R.; Otrock Z.K.; Alameddine R.S.; Awada A.H.; Shamseddine A.
(NEW YORK360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, 2012)
Despite major advances in cancer therapeutics, the prognosis for lung cancer patients is still poor and the median survival for patients presenting with advanced non-small cell lung cancer (NSCLC) is only 8-10. months. ...